Page 18 - Immunizations News Today

The use of nirmatrelvir–ritonavir (Paxlovid) is associated with a lower risk for death or hospitalization in extremely vulnerable patients with COVID-19. Low-risk patients do not appear to benefit.

Novavax's Covid shot is arriving nearly three weeks after new jabs from Pfizer and Moderna reached Americans — but analysts aren't worried about that delay. 

By Adriano Marchese Moderna has filed a new drug submission to Canadian health regulators for an investigational vaccine aimed at preventing RSV in older...

Around 4 million Americans received the updated COVID-19 shots in September, even as some people have found it difficult to book vaccination appointments or find the vaccines at no cost.

The combination vaccine has acceptable side effects and could be ready to launch as early as 2025, according to Moderna.

The FDA said on Tuesday it authorized an updated version of Novavaxs COVID-19 vaccine for emergency use in individuals aged 12 years and older.

Now that COVID-19 vaccines are not being distributed by the federal government, the US Centers for Disease Control and Prevention has stopped printing new cards.

Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination vaccine against COVID-19 and flu on Wednesday.

Stock jumps 12% on regulatory approval of new shot

The agency approved competing vaccines from Pfizer-BioNTech and Moderna last month.